These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26322762)

  • 1. Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters.
    Shteinberg M; Kis-Papo T; Millar BC; Rendall JC; Downey DG; Elborn JS; Moore JE
    J Water Health; 2015 Sep; 13(3):773-6. PubMed ID: 26322762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production.
    Lightly TJ; Phung RR; Sorensen JL; Cardona ST
    Can J Microbiol; 2017 May; 63(5):427-438. PubMed ID: 28178425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the multifaceted iron acquisition strategies of Burkholderia cenocepacia.
    Tyrrell J; Whelan N; Wright C; Sá-Correia I; McClean S; Thomas M; Callaghan M
    Biometals; 2015 Apr; 28(2):367-80. PubMed ID: 25725797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the biocide Steri-7 against the common Gram-negative bacterial pathogens (Burkholderia cenocepacia, Burkholderia gladioli, Burkholderia multivorans, Pseudomonas aeruginosa and Stenotrophomonas maltophilia) associated with cystic fibrosis (CF).
    Moore JE; Rao JR
    Br J Biomed Sci; 2013; 70(2):80-1. PubMed ID: 23888610
    [No Abstract]   [Full Text] [Related]  

  • 6. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).
    Caskey S; Moore JE; McCaughan J; Rendall JC
    Br J Biomed Sci; 2018 Apr; 75(2):101-103. PubMed ID: 29513134
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.
    Costello A; Reen FJ; O'Gara F; Callaghan M; McClean S
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1474-1487. PubMed ID: 24790091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice.
    Chattoraj SS; Murthy R; Ganesan S; Goldberg JB; Zhao Y; Hershenson MB; Sajjan US
    Infect Immun; 2010 Mar; 78(3):984-93. PubMed ID: 20048042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response.
    Bragonzi A; Farulla I; Paroni M; Twomey KB; Pirone L; Lorè NI; Bianconi I; Dalmastri C; Ryan RP; Bevivino A
    PLoS One; 2012; 7(12):e52330. PubMed ID: 23284990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
    Wright C; Pilkington R; Callaghan M; McClean S
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L575-86. PubMed ID: 21743026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Berlutti F; Superti F; Nicoletti M; Morea C; Frioni A; Ammendolia MG; Battistoni A; Valenti P
    Int J Immunopathol Pharmacol; 2008; 21(1):51-9. PubMed ID: 18336731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa displays an altered phenotype in vitro when grown in the presence of mannitol.
    Moore JE; Rendall JC; Downey DG
    Br J Biomed Sci; 2015; 72(3):115-9. PubMed ID: 26510267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P; Widmer F; Middleton PG; Iredell J; George AM
    FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Motility Favors Codependent Interaction between Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Morin C; Landry M; Groleau MC; Déziel E
    mSphere; 2022 Aug; 7(4):e0015322. PubMed ID: 35862793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental persistence of Pseudomonas aeruginosa and Burkholderia multivorans in sea water: preliminary evidence of a viable but non-culturable state.
    Moore JE; Nagano Y; Millar BC; McCalmont M; Elborn JS; Rendall J; Pattison S; Dooley JS; Goldsmith CE
    Br J Biomed Sci; 2007; 64(3):129-31. PubMed ID: 17910284
    [No Abstract]   [Full Text] [Related]  

  • 17. Which pathogens should we worry about?
    Jones AM
    Paediatr Respir Rev; 2019 Aug; 31():15-17. PubMed ID: 30967346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AR-13 reduces antibiotic-resistant bacterial burden in cystic fibrosis phagocytes and improves cystic fibrosis transmembrane conductance regulator function.
    Assani K; Shrestha CL; Rinehardt H; Zhang S; Robledo-Avila F; Wellmerling J; Partida-Sanchez S; Cormet-Boyaka E; Reynolds SD; Schlesinger LS; Kopp BT
    J Cyst Fibros; 2019 Sep; 18(5):622-629. PubMed ID: 30366849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
    Mil-Homens D; Bernardes N; Fialho AM
    FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.